Officer received an award of 3,625 HALO derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Oct 3, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Oct 6, 2025
OfficerGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0002090209-25-000005
- Filed / recorded
Oct 6, 2025, 9:18 PM UTCAdded to OQROOct 6, 2026, 7:59 PM UTC Data qualityVerified: identifiers matched exactly IssuerHALOZYME THERAPEUTICS, INC. Reporting personCortney Caudill Officer titleSVP, CHIEF OPERATING OFFICER SecurityRestricted Stock Units TableDerivative (Table II) Transaction dateOct 3, 2025 Acquired / disposedAcquired (A) Footnotes from the filing
- This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.
Around the same time
Traded Oct 3, 2025 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.